Intellect Neurosciences, Inc. Validates Pivotal European Patent ... - MarketWatch
Intellect Neurosciences, Inc. Validates Pivotal European Patent ... MarketWatch - a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease (AD), ... Intellect Neurosciences, Inc. Validates Pivotal European Patent ... |
Original post: Intellect Neurosciences, Inc. Validates Pivotal European Patent ... - MarketWatch by ©2008 Google at alzheimers treatment - Google News
Blog tag: Alzheimers treatment
Technorati tag: Alzheimers treatment